You searched for Economics of Innovation

We found for

News
January 2023

Professor Aidan Hollis wins first £40,000 OHE Policy Innovation Prize

On a dollar bill are pills of a medicine capsule.

Blog
June 2022

Estimating the Impact of U.S. Drug Price-setting Policies on Innovation Is Challenging, Even for the Congressional Budget Office

News
March 2022

Economist Vacancy at the OHE

Adult and child hands holding lung, world tuberculosis day, worl

Blog
March 2022

Invest to End TB. Save Lives. World TB Day 2022. Reflections on 60 years of OHE publications on TB.

Blog
February 2022

How Does Pharmaceutical Spending Drive Innovation in Europe?

Blog
December 2021

OHE Critique of CBO’S Pharmaceutical Investment Model Provides Warning for Policymakers on Reliability of Estimates

Past Event
Annual lecture
September 2021

Virtual OHE Annual Lecture 2021: Do Patents Work? Evidence from Pharmaceutical Innovation

Blog
September 2021

Does the New CBO Report Change Anything?

Blog
September 2021

Due to the Unprecedented Nature of H.R. 3, the CBO Analysis is Unreliable and Can’t Inform Policymaking

Blog
September 2021

CBO Doesn’t Capture The Real Impact of H.R. 3 on Innovation

Blog
September 2021

The CBO Doesn’t Understand Investors

Blog
September 2021

H.R. 3 is the Wrong Policy for the Wrong Problem

Blog
September 2021

OHE is Launching a New Series to Explore the Latest Attempts to Reduce the Cost of US Healthcare

Blog
July 2021

How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine? Where are we 6 Months on?

Blog
May 2021

Would Waiving COVID-19 Vaccines Patents Save Lives?

Latest Research & Publications

All Publications

We found for

Filter results by

Professor Aidan Hollis wins first £40,000 OHE Policy Innovation Prize

Estimating the Impact of U.S. Drug Price-setting Policies on Innovation Is Challenging, Even for the Congressional Budget Office

Economist Vacancy at the OHE

Invest to End TB. Save Lives. World TB Day 2022. Reflections on 60 years of OHE publications on TB.

How Does Pharmaceutical Spending Drive Innovation in Europe?

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

OHE Critique of CBO’S Pharmaceutical Investment Model Provides Warning for Policymakers on Reliability of Estimates

Virtual OHE Annual Lecture 2021: Do Patents Work? Evidence from Pharmaceutical Innovation

Does the New CBO Report Change Anything?

Due to the Unprecedented Nature of H.R. 3, the CBO Analysis is Unreliable and Can’t Inform Policymaking

CBO Doesn’t Capture The Real Impact of H.R. 3 on Innovation

The CBO Doesn’t Understand Investors

H.R. 3 is the Wrong Policy for the Wrong Problem

OHE is Launching a New Series to Explore the Latest Attempts to Reduce the Cost of US Healthcare

How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine? Where are we 6 Months on?

Would Waiving COVID-19 Vaccines Patents Save Lives?